+7(499)110-40-67 
+7(495)150-11-22 
+7(800)250-87-00 
PATIENT GUIDE: BENIGN OVARIAN TUMORS
Ovarian tumors are pathological formations that can be benign, borderline, or malignant in nature. They arise due to disruptions in the process of cell division. Approximately 80% of all ovarian tumors are benign, though some may transform into malignant ones over time.
“Early detection and removal of ovarian tumors play a key role in preventing ovarian cancer,” notes Yulia Aldushkina, obstetrician-gynecologist of the reconstructive-plastic gynecology and oncology department at the N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology – branch of the Federal State Budgetary Institution of the “National Medical Research Radiological Centre” of the Ministry of Health of the Russian Federation.
Benign ovarian tumors are divided into several main groups:
1. Epithelial tumors:
- Serous: cystadenoma and papillary cystadenoma, surface papilloma, adenofibroma, and cystadenofibroma.
- Mucinous: cystadenoma, adenofibroma, and cystadenofibroma.
- Endometrioid: adenofibroma, cystadenofibroma, adenoma, and cystadenoma.
- Clear cell or mesonephroid: adenofibroma.
- Brenner tumors (benign).
- Mixed epithelial (benign).
2. Sex cord-stromal tumor: thecoma, fibroma.
3. Germ cell tumors: dermoid cysts, struma ovarii.
4. Tumor-like processes:
- follicular cysts;
- corpus luteum cysts;
- endometrioid cysts;
- simple cysts;
- inflammatory processes;
- paraovarian cysts.
It should be noted that some benign tumors can be hormonally active, leading to changes in a woman’s hormonal background.
Symptoms of Benign Ovarian Tumors
In the early stages, benign ovarian tumors often present no symptoms, making early detection difficult. However, as the tumor grows, symptoms such as dull abdominal pain not associated with menstruation, abdominal swelling or bloating, and frequent urination may occur.
Diagnosis and Treatment of Benign Tumors
“Transabdominal and transvaginal ultrasound can accurately differentiate benign tumors in 96% of cases,” explains Yulia Vladimirovna. In more complex situations, specialists recommend CT or MRI. “Determining tumor marker levels is also an important step in diagnosing malignant changes,” adds the expert.
The treatment strategy for benign tumors depends on the patient’s age, reproductive plans, and the tumor’s histological type. In some cases, it is possible to preserve healthy ovarian tissue, which is especially important for women planning pregnancy. In other situations, removal of the affected ovary or even the uterine appendages may be required.
Specialists at the National Medical Research Radiological Centre provide consultations and modern treatment methods. Appointments can be made through the contact center: 8 499 110-40-67, 8 495 150-11-22, 8 800 250-87-00.
